MOH — authorised 24 December 1953
- Marketing authorisation holder: ENDO PHARMS
- Status: likely_approved
🇮🇱 Xyosted (Autoinjector) in Israel
MOH authorised Xyosted (Autoinjector) on 24 December 1953
Marketing authorisation
Xyosted (Autoinjector) in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Israel
Frequently asked questions
Is Xyosted (Autoinjector) approved in Israel?
Yes. MOH authorised it on 24 December 1953.
Who is the marketing authorisation holder for Xyosted (Autoinjector) in Israel?
ENDO PHARMS holds the Israeli marketing authorisation.